Fredun Pharmaceuticals Limited (BOM:539730)
India · Delayed Price · Currency is INR 1,473.70
-19.75 (-1.32%)
At close: Nov 6, 2026
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 24.37 billion as of November 6, 2026. It is the 18,821st most valuable company in the world and the 1,156th biggest in India. Its market cap has increased by 233.80% in one year.
Market Cap
24.37B
Enterprise Value
26.35B
Revenue
8.66B
Global Rank
Country Rank
#1,156 India
PE Ratio
53.29
ChartMarket Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.40M to 24.37B, an increase of 82,784.40%. That is a compound annual growth rate of 88.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 24.37B | 227.05% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 43.65B |
| Evonile Pharma | 42.33B |
| Kwality Pharmaceuticals | 38.28B |
| SHUKRA MEDTECH LIMITED | 35.13B |
| Unichem Laboratories | 34.75B |
| Hikal | 27.24B |
| Syncom Formulations (India) | 19.62B |
| Venus Remedies | 19.44B |